Testing for Anti-reticulin Antibodies in Celiac Disease is Obsolete: A Review of Recommendations for Serologic Screening and the Literature.

Department of Pathology, University of Utah, Salt Lake City, UT.
Clinical and vaccine Immunology: CVI (Impact Factor: 2.47). 01/2013; 20(4). DOI: 10.1128/CVI.00568-12
Source: PubMed


Celiac disease (CD) is an autoimmune disorder that occurs in genetically susceptible individuals of all ages and is triggered by immune response to gluten and related proteins. The disease is characterized by the presence of HLA-DQ2 and/or DQ8 haplotypes, diverse clinical manifestations, gluten-sensitive enteropathy and production of several autoantibodies of which endomysial, tissue transglutaminase and deamidated gliadin peptide antibodies are considered specific. Although anti-reticulin antibodies (ARA) have historically been used in the evaluation of CD, these assays lack optimal sensitivities and specificities for routine diagnostic use. This review highlights the advances in CD-specific serologic testing and the rationale for eliminating ARA from CD evaluation consistent with recommendations for diagnosis.

Download full-text


Available from: Anne E Tebo, May 05, 2014
1 Follower
46 Reads